No. 7 / 31 January 2023
To: BUCHAREST STOCK EXCHANGE
FINANCIAL SUPERVISORY AUTHORITY
CURRENT REPORT
In accordance with Law no. 24/2017 on issuers of financial instruments and market operations (republished) and FSA Regulation no. 5/2018 on issuers of financial instruments and market operations
Report Date: 31 January 2023
Name of the issuing company: MED LIFE S.A. ("MedLife" or "The Company")
Unique Registration Code at the National Office of Trade Registry: 8422035
Order number on the Trade Registry: J40/3709/1996
Subscribed and paid-in share capital: 33,217,623 RON
Regulated market on which the issued securities are traded: Bucharest Stock Exchange, Premium Category
Significant events to report: Auditor report according with art. 108 of Law no. 24/2017 republished, for the Second Semester of 2022
The company informs the shareholders about the publishing of the Independent Limited Assurance Report for the Second Semester of 2022, prepared by the financial auditor Ernst & Young Assurance Services SRL, on the information included in the current reports issued by the company in accordance with the requirements of Article 108 of Law 24/2017, with all subsequent changes and clarifications, and with the provisions FSA Regulation no. 5/2018.
The report can be consulted by accessing the link below.
__________________
Mihail Marcu
Chief Executive Officer